XBIO Xenetic Biosciences, Inc.: Narxning prognoz qilingan daromadga nisbati

Xenetic Biosciences Inc. (XBIO) brendining ramzi va logotipi

Xenetic Biosciences (XBIO) uchun forward P/S tendentsiyasi o'smalarga qarshi kurashish uchun ferment platformalarining dastlabki preklinik sinovlariga asoslangan. Kompaniyaning joriy salohiyati XCART shaxsiylashtirilgan T-hujayrali terapiya tizimiga tayanadi, biznesni rivojlantirish esa immunoterapiyani takomillashtirish maqsadida tibbiyot markazlari bilan hamkorlik orqali tezlashmoqda. Shu bilan birga, 1.20 yangi daraja qiymatini ifodalaydi, bu esa emitentning kelgusidagi daromadlariga nisbatan bozor kutganlarini baholashga yordam beradi.

Xenetic Bio - XBIO Bozor kapitallashuvining kelajakdagi daromadga nisbati (davr: 04.07.2022 - 17.11.2026)

Xenetic Biosciences kompaniyasining tahliliy kesimlari

- joriy narx va aksiyalarning prognoz qilingan qiymati:
- kompaniya aksiyalari kapitallashuvi ma'lumotlari:
Kompaniyaning barcha koʻrsatkichlari tahlili:Xenetic Biosciences, Inc. (XBIO)
xeneticbio.com tovar namunasi

Xenetic Biosciences (XBIO) kompaniyasining tebranishlarga chidamliligi litsenziyalar va onkologiya platformalarining monetizatsiyasiga bog'liq bo'lib, bu kutilayotgan pul oqimlarining bozor qiymatiga bevosita ta'sir qiladi. Forward P/S tendentsiyasini tahlil qilish orqali investor kelajakdagi daromad birligining qiymatini aniqlashi mumkin, bunda grafikdagi keskin ko'tarilishlar inqiroz paytida pozitsiyadan tezda chiqishga urinishda aktivlar likvidligining pastligi xavfidan signal beradi.

Muhim raqobatchilar

Forvard P/S multiplikatori ONC (BeiGene Oncology)|Forvard P/S multiplikatori Halozyme Corp HALO|RVMD: Forvard narx/daromad multiplikatori|Ascentage Pharma Group (AAPG) - Forvard narx/daromad multiplikatori|CG Oncology Therapeutics (CGON) - Narxning prognoz qilingan daromadga nisbati|Prognoz narxning daromadga nisbati UroGen Pharma URGN|Narxning prognoz qilingan daromadga nisbati Bicara Bio|Bozor kapitallashuvining kelajakdagi daromadga nisbati Personalis Genomics PSNL|Forvard P/S multiplikatori ERAS|Narxning kutilayotgan daromadga nisbati DCTH|Y-mAbs Therapeutics, Inc. - Forvard narx/daromad multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Aura Biosciences Inc (AURA)|CADL: Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx ARAY (Accuray Inc.)|SLS: Forvard P/S multiplikatori|ACTU: Narxning kutilayotgan daromadga nisbati|CTOR (Citius Oncology Inc.) - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati tuhurabio.com HURA|Forvard P/S multiplikatori TARA|FATE: Kelajakdagi narxning daromadga nisbati|Forvard P/S multiplikatori WHWK (Aadi Bioscience)|TCRX (TScan) - Kelajakdagi narxning daromadga nisbati|Champions Oncology, Inc. - Forvard P/S multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati XBiotech Inc XBIT|CVM: Forvard P/S multiplikatori|OSTX - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati Radiopharm Theranostics Limited|Forvard P/S multiplikatori artivabio.com|Forvard narx/daromad multiplikatori ANL (Adlai Nortye Limited)|Veru - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Tempest Therapeutics, Inc. - Forvard narx/daromad multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati xiliotx.com (XLO)|Renovaro - Forvard P/S multiplikatori|Mural Oncology (MURA) - Forvard narx/daromad multiplikatori|KAPA: Forvard P/S multiplikatori|OKUR - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati CytoMed Therapeutics Limited|CRIS: Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori APLM|Forvard P/S multiplikatori tharimmune.com (THAR)|Advanced Biomed Corp - Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx GNPX|Calidi Biotherapeutics, Inc. - Forvard P/S multiplikatori|Sunshine Biopharma (SBFM) - Forvard narx/daromad multiplikatori|salariuspharma.com (SLRX) - Narxning prognoz qilingan daromadga nisbati|Purple Biotech Ltd. - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati AON|Forvard P/S multiplikatori BeiGene Ltd.|Narxning prognoz qilingan daromadga nisbati Checkpoint Therapeutics, Inc. (CKPT)|Forvard narx/daromad multiplikatori Elevation Oncology, Inc. ELEV|Forvard P/S multiplikatori ICAD (iCAD Inc.)|IKNA - Forvard narx/daromad multiplikatori|NTBL: Forvard narx/daromad multiplikatori|viracta.com (VIRX) - Forvard narx/daromad multiplikatori|MorphoSys (MOR) - Narxning prognoz qilingan daromadga nisbati|NAYA Biosciences Corp (NAYA) - Forvard P/S multiplikatori|AAPGV (Ascentage) - Forvard P/S multiplikatori